Umberto Ricardi
Papers
5
Total Citations
164
H-Index
4
About
Umberto Ricardi is a leading figure in urologic oncology, with a primary focus on salvage therapies for recurrent prostate cancer. His most impactful work centers on the evolution of salvage radical prostatectomy, where he has been instrumental in demonstrating that robotic approaches can significantly reduce morbidity and improve functional outcomes compared to traditional open surgery. A landmark 2019 multicenter study (91 citations) provided critical evidence that modern salvage prostatectomy is a viable, safer option for patients with biochemical recurrence after primary radiotherapy. Ricardi’s subsequent 2021 work (42 citations) further validated these oncological outcomes, establishing a new standard of care in a historically challenging clinical scenario. Beyond prostate cancer, his research spans thoracic and hematologic malignancies, including a comprehensive review of early-stage lung cancer progress and dosimetric studies on proton therapy for mediastinal Hodgkin lymphoma. Through large-scale Italian registry analyses (e.g., MIRROR-SIU/LUNA and Pros-IT CNR), Ricardi has also documented the national shift toward minimally invasive techniques, shaping surgical practice and patient counseling. His contributions bridge surgical innovation with real-world evidence, making him a key voice in the contemporary management of recurrent prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Early Stage Lung Cancer: Progress in the Last 40 Years22 citations · 2014
- 4
- 5